Most importantly, PTEN overexpression blocked GRP-mediated tumor progression as assessed by in vitro functional assays, thereby, demonstrating the critical role of PTEN in reversing the oncogenic roles of GRP in neuroblastoma. The gene discussed is GRP; the disease is neuroblastoma.